Drug Testing Locations - Parkside, PA

Drug Testing in Parkside, PA

Parkside, Pennsylvania Statistics

Parkside, PA, in Delaware County, reported a 15% increase in opioid overdoses from 2020 to 2021.

In 2021, 60% of drug-related arrests in Parkside involved individuals under the age of 30.

Delaware County, including Parkside, documented over 1,200 admissions to drug treatment programs in 2022.

Parkside saw a 30% increase in naloxone administrations by first responders in 2022.

In 2022, Delaware County experienced a 25% increase in opioid-related deaths, impacting areas like Parkside.

In 2023, Parkside, PA, recorded 75 incidents of drug possession, a rise compared to previous years.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Parkside, PA & Drug Testing Policies

Many employers in Parkside, PA enforce strict drug testing policies to ensure workplace safety. Companies are required to abide by statewide regulations detailed by the Pennsylvania Department of Labor & Industry, which supports maintaining drug-free environments.

Employers in Parkside often conduct pre-employment drug screenings as part of their recruitment process. Continued random drug testing and safety protocols are essential for compliance with both state-level requirements and federal guidelines by the U.S. Department of Labor.

Government Efforts with Drug Problems in Parkside, PA

The government has implemented multiple strategies to combat drug issues in Parkside, PA. Local law enforcement agencies and the Delaware County Health Department collaborate to provide community outreach and educational programs focusing on drug prevention. Delaware County Health Department

State and federal grants aid local initiatives to reduce drug abuse in Parkside. The involvement of the CDC helps enhance efforts, from increasing naloxone availability to improving access to treatment services. These comprehensive plans target the root causes and provide critical support.

Local Drug Busts & News in Parkside, PA

Recently, significant drug busts have occurred in Parkside, PA, as local law enforcement has ramped up efforts. In a multi-agency operation involving the Delaware County Drug Task Force, a sizeable quantity of controlled substances was seized, marking a substantial disruption to local drug trafficking.

Events focusing on drug abuse awareness drive community engagement. Annual gatherings, workshops, and seminar series highlight rehabilitation success stories and preventive strategies. Such events foster an informed community eager to combat the issue collaboratively.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Parkside, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

Pennsylvania Department of Drug and Alcohol Programs

Substance Abuse and Mental Health Services Administration

Delaware County Crime Victims Center

Partnership to End Addiction

Nar-Anon Family Groups

Narcotics Anonymous

Addiction Center

LACA Network

Drug Testing Near Parkside, PA

Folsom, PA

Swarthmore, PA

Ridley Park, PA

Village Green, PA

Woodlyn, PA

Rose Valley, PA

Village Green-Green Ridge, PA

Eddystone, PA

Nether Providence Township, PA

Chester Township, PA

Upland, PA

Brookhaven, PA

Frequently Asked Questions

Customer Reviews